Ruth Suk-Mei Chan
Overview
Explore the profile of Ruth Suk-Mei Chan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
841
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma S, Wu J, Zhu L, Chan R, Wang X, Huang D, et al.
Nutrients
. 2021 Aug;
13(7).
PMID: 34371826
Background: Sarcopenia is a major health problem in older adults. Exercise and nutrient supplementation have been shown to be effective interventions but there are limited studies to investigate their effects...
2.
Chan R, Tam W, Ho I, Kwan M, Li L, Sea M, et al.
Sci Rep
. 2018 Sep;
8(1):13849.
PMID: 30218012
Gestational diabetes mellitus (GDM) is of public health concern. This trial examined whether a clinically proven lifestyle modification program (LMP) in early pregnancy was superior to routine antenatal care in...
3.
Wong V, Wong G, Chan R, Shu S, Cheung B, Li L, et al.
J Hepatol
. 2018 Aug;
69(6):1349-1356.
PMID: 30142427
Background & Aims: Around 10-20% of patients with non-alcoholic fatty liver disease (NAFLD) are non-obese. The benefit of weight reduction in such patients is unclear. We aim to study the...
4.
Wei J, Leung J, Loong T, Wong G, Yeung D, Chan R, et al.
Am J Gastroenterol
. 2015 Jul;
110(9):1306-14.
PMID: 26215532
Objectives: Some studies suggest that non-obese patients with nonalcoholic fatty liver disease (NAFLD) may have more severe disease. We aim to study the epidemiology and severity of non-obese NAFLD. Methods:...
5.
Wong V, Wong G, Yeung D, Lau T, Chan C, Chim A, et al.
J Hepatol
. 2014 Sep;
62(1):182-9.
PMID: 25195550
Background & Aims: Because abdominal ultrasonography cannot reliably quantify hepatic steatosis, accurate data on the incidence of non-alcoholic fatty liver disease (NAFLD) are lacking. We aimed to study the population...
6.
Shen J, Wong G, Chan H, Chan R, Chan H, Chu W, et al.
J Gastroenterol Hepatol
. 2014 Jul;
30(1):139-46.
PMID: 25040896
Background And Aim: Lifestyle modification is the cornerstone for the management of nonalcoholic fatty liver disease (NAFLD), and patatin-like phospholipase 3 (PNPLA3) is one of the most important genetic determinants...
7.
Wong V, Wong G, Yeung D, Abrigo J, Kong A, Chan R, et al.
Am J Gastroenterol
. 2014 Feb;
109(4):589-97.
PMID: 24492753
Objectives: Nonalcoholic fatty liver disease is the most common chronic liver disease. Fatty pancreas has also been described but is difficult to assess. It is now possible to measure pancreatic...
8.
Wong V, Chan R, Wong G, Cheung B, Chu W, Yeung D, et al.
J Hepatol
. 2013 Apr;
59(3):536-42.
PMID: 23623998
Background & Aims: Healthy lifestyle is the most important management of non-alcoholic fatty liver disease (NAFLD). This study aimed at assessing the efficacy of a community-based lifestyle modification programme in...
9.
Wong V, Chu W, Wong G, Chan R, Chim A, Ong A, et al.
Gut
. 2011 Aug;
61(3):409-15.
PMID: 21846782
Objective: Knowledge of the epidemiology of non-alcoholic fatty liver disease (NAFLD) is incomplete because liver biopsy cannot be performed on the general population to assess disease severity. New non-invasive tests...